Taiwan FDA registration 1fa0e5b8c20ecd6ec630d8157c24fc1e
AP-10 Blood Glucose Monitoring System
TW: 測糖穩血糖測試系統
Taiwan·Risk Class 2·MD·LEISON BIOTECH CO., LTD.·Registered Aug 02, 2018 – Aug 02, 2028ActiveRegistration details
- Analysis ID
- 1fa0e5b8c20ecd6ec630d8157c24fc1e
- License Form
- Ministry of Health Medical Device Manufacturing No. 005994
Company information
- Manufacturer
- LEISON BIOTECH CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- LEISON BIOTECH CO., LTD.
Product details
- Intended Use
- This product is intended for self-quantitative detection of fingertip microvascular whole blood and professional quantitative detection of glucose in venous whole blood blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1345 Glucose Test System
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Aug 02, 2018
- Expiry Date
- Aug 02, 2028
About this record
Access comprehensive regulatory information for AP-10 Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1fa0e5b8c20ecd6ec630d8157c24fc1e and manufactured by LEISON BIOTECH CO., LTD.. The authorized representative in Taiwan is LEISON BIOTECH CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices